Argonaut Therapeutics
Oxford
About Argonaut Therapeutics
Argonaut Therapeutics is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: M&A
- Last round: Corporate Round (Oct 2018)
- Website: argonauttherapeutics.co.uk
- Phone: [email protected]
Industries & Categories
Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/argonaut-therapeutics-5114 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.